Investment opportunity in biosimilars and its impact on firms’ capital structure: Evidence from drug manufacturing companies (No Full Text)

Simple item page
dc.contributor.authorAlenaizi, Rand
dc.contributor.authorVarghese, Shama Mary
dc.contributor.authorTiwari, Manjari
dc.contributor.authorElshareif, Elgilani
dc.contributor.authorContu, Davide
dc.date.accessioned2024-09-20T07:03:24Z
dc.date.available2024-09-20T07:03:24Z
dc.date.issued2024
dc.identifier.citationAlenaizi, R., Varghese, S. M., Tiwari, M., Elshareif, E., & Contu, D. (2024). Investment opportunity in biosimilars and its impact on firms’ capital structure: Evidence from drug manufacturing companies. In Studies in Systems, Decision and Control (Vol. 525). https://doi.org/10.1007/978-3-031-54383-8_54
dc.identifier.issn21984182
dc.identifier.urihttps://hdl.handle.net/20.500.12519/1085
dc.identifier.urihttps://doi.org/10.1007/978-3-031-54383-8_54
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relationAuthors Affinations : Alenaizi, R., Varghese, S. M., Tiwari, M., Elshareif, E., & Contu, D., Canadian University Dubai, Dubai, United Arab Emirates
dc.relation.ispartofseriesStudies in Systems, Decision and ControlVolume 525, Pages 701 - 712
dc.subjectBiosimilars
dc.subjectCapital structure change
dc.subjectInvestment opportunity
dc.titleInvestment opportunity in biosimilars and its impact on firms’ capital structure: Evidence from drug manufacturing companies (No Full Text)
dc.typeBook chapter

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Access Instruction_1085.pdf
Size:
106.1 KB
Format:
Adobe Portable Document Format
Download

Collections

School of Management